Upgrade to SI Premium - Free Trial

PolyPid Ltd. (PYPD)

5.25 +0.12 (2.34%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

PolyPid to Present D-PLEX₁₀₀ Microbiology Data at IDWeek 2026 October 21, 2026 8:00 AM - StreetInsider PolyPid to Host Virtual Investor Day on Wednesday, October 28, 2026 October 15, 2026 8:30 AM - StreetInsider Form 6-K PolyPid Ltd. For: Oct 01 October 1, 2026 9:20 AM - SEC Filing EMA validates PolyPid's marketing application for D-PLEX100 October 1, 2026 9:15 AM - StreetInsider European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀ October 1, 2026 9:15 AM - StreetInsider Form 6-K PolyPid Ltd. For: Oct 01 October 1, 2026 9:01 AM - SEC Filing PolyPid regains European rights to D-PLEX100 after ADVANZ deal ends October 1, 2026 8:56 AM - StreetInsider PolyPid Regains European Commercialization Rights for D-PLEX₁₀₀, Expanding Global Commercialization Opportunities October 1, 2026 8:56 AM - StreetInsider PolyPid Announces Participation in Upcoming Fall Investor Conferences September 15, 2026 8:30 AM - StreetInsider Form SCHEDULE 13G/A PolyPid Ltd. Filed by: Centaurus Investments Ltd August 13, 2026 4:27 PM - SEC Filing Form 6-K PolyPid Ltd. For: Jun 30 August 12, 2026 4:59 PM - SEC Filing Form S-8 PolyPid Ltd. August 12, 2026 4:02 PM - SEC Filing Form SCHEDULE 13G/A PolyPid Ltd. Filed by: Rosalind Advisors, Inc. August 12, 2026 2:00 PM - SEC Filing PolyPid Ltd. (PYPD) Tops Q2 EPS by 5c August 12, 2026 7:47 AM - StreetInsider Form 6-K PolyPid Ltd. For: Aug 12 August 12, 2026 7:35 AM - SEC Filing PolyPid Provides Corporate Update and Reports Second Quarter 2026 Financial Results August 12, 2026 7:30 AM - StreetInsider PolyPid to Report Second Quarter 2026 Financial Results and Operational Highlights on August 12, 2026 July 30, 2026 8:00 AM - StreetInsider Form 6-K PolyPid Ltd. For: Jul 29 July 29, 2026 8:35 AM - SEC Filing FDA accepts PolyPid's D-PLEX100 NDA with priority review July 29, 2026 8:30 AM - StreetInsider PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀ July 29, 2026 8:30 AM - StreetInsider Full Article List